why choose us

First received: November 07, 2023

Clinical Trial: Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Androgen Deprivation Therapy

Study Type: INTERVENTIONAL


Official Title: Phase IB Trial of Relugolix and Enzalutamide as Neoadjuvant/ Adjuvant to Local-regional Treatment in Patients With High-risk Locally Advanced Prostate CAncer (RENAPCA)

Brief Summary: The goal of this clinical trial is to test how effective and safe it is to use a combination of two medications, relugolix and enzalutamide, in patients with advanced prostate cancer.We want to see if this combination can help improve the chances of curing the cancer and make the patients live longer without the cancer getting worse.The main questions we want to answer in this study are:Can using relugolix and enzalutamide together help increase the chances of curing high-risk advanced prostate cancer?Does this…

Read more